|1.||Martínez-Fernández, A R: 3 articles (09/2007 - 03/2003)|
|2.||Escario, J A: 2 articles (12/2003 - 03/2003)|
|3.||Gómez-Barrio, A: 2 articles (12/2003 - 03/2003)|
|4.||Nogal-Ruiz, J J: 2 articles (12/2003 - 03/2003)|
|5.||Navarro-Zorraquino, M: 1 article (09/2007)|
|6.||Lozano, R: 1 article (09/2007)|
|7.||Salinas, J C: 1 article (09/2007)|
|8.||García-Alvarez, F: 1 article (09/2007)|
|9.||Pastor, C: 1 article (09/2007)|
|10.||Larrad, L: 1 article (09/2007)|
|1.||Alzheimer Disease (Alzheimer's Disease)
09/01/2000 - "As compared to placebo, anapsos (360 mg/day) induced a significant improvement in ADAScog scores in mild senile dementia patients (p < 0.01) and in the subset of patients with AD (p < 0.05). "
09/01/2000 - "The aim of this study was to evaluate the effects of two doses of anapsos in comparison with placebo on cognitive performance, brain bioelectrical activity pattern and cerebral hemodynamic parameters in patients with mild to moderate senile dementia of vascular type and Alzheimer type. "
09/01/2000 - "The present results show that anapsos (360 mg/day) improves cognitive performance, cerebral blood perfusion and brain bioelectrical activity in patients with senile dementia. "
09/01/2000 - "Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics."
|2.||Asthma (Bronchial Asthma)
|3.||Psoriasis (Pustulosis Palmaris et Plantaris)
01/01/1983 - "A personal experience on 495 patients affected by several forms of psoriasis and its answer to the treatment with anapsos (Polypodium Leucotomos Extract) is presented. "
01/01/1983 - "[2 years personal experience in anapsos treatment of psoriasis in various clinical forms]."
01/01/1982 - "The absence of side effects, minimum intolerance of product and the amount of obtained successes make the authors to consider the future of anapsos optimistically for the treatment of psoriasis."
01/01/1982 - "[Comparative study between 120 mg. of anapsos and a placebo in 37 psoriasis patients]."
09/01/1981 - "[Double-blind study using "anapsos" 120 mg. in the treatment of psoriasis]."
|4.||Atopic Dermatitis (Atopic Eczema)
07/01/1987 - "Anapsos, an antipsoriatic drug, in atopic dermatitis."
01/01/1986 - "Anapsos modifies immunological parameters and improves the clinical course in atopic dermatitis."
07/01/1987 - "An open, controlled study was carried out in young patients with atopic dermatitis, who during one month received oral anti-psoriatic drug, anapsos (n = 46), or antihistamines (n = 30), simultaneously with topic applications. "
|5.||Laryngeal Neoplasms (Laryngeal Cancer)
01/01/1982 - "It is presented a comparative and clinical study on 37 patients affected by psoriasis, 13 of them took placebo and 22 finished treatment with Anapsos in capsules of 120 mg. One patient abandoned treatment by intolerance and another one with possible laryngeal neoplasm, the drug showed a discordant result. "
|1.||Histamine Antagonists (Antihistamines)
|3.||Interleukin-1beta (Interleukin 1 beta)
|4.||NF-kappa B (NF-kB)
|5.||Transcription Factors (Transcription Factor)